Arsia Therapeutics Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $78.2M

Arsia Therapeutics General Information

Description

Operator of a biopharmaceutical company intended to develop innovative protein formulation. The company produces concentrated drugs and related products with low viscosity, suitable for small-volume subcutaneous injection, enabling clients to avail improved access to highly viscous protein therapeutics.

Contact Information

Website
www.arsiarx.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Kendall Square
  • Cambridge, MA
  • United States
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Kendall Square
  • Cambridge, MA
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Arsia Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 16-Nov-2016 $78.2M Completed Generating Revenue
3. Early Stage VC 01-Jan-2015 Completed Startup
2. Accelerator/Incubator Completed Startup
1. Accelerator/Incubator Completed Startup
To view Arsia Therapeutics’s complete valuation and funding history, request access »

Arsia Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biopharmaceutical company intended to develop innovative protein formulation. The company produces concent
Drug Delivery
Cambridge, MA

San Ramon, CA
 

Hertfordshire, United Kingdom
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Arsia Therapeutics Competitors (21)

One of Arsia Therapeutics’s 21 competitors is RheoSense Inc., a Corporation company based in San Ramon, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
RheoSense Inc. Corporation San Ramon, CA
Antibody Production Services Corporation Hertfordshire, United Kingdom
Domainex Venture Capital-Backed Saffron Walden, United Kingdom
Agrisera Formerly PE-Backed Vannas, Sweden
Protein Ark Private Equity-Backed Rotherham, United Kingdom
You’re viewing 5 of 21 competitors. Get the full list »

Arsia Therapeutics Patents

Arsia Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2016054259-A1 Polysaccharide and nucleic acid formulations containing viscosity-lowering agents Inactive 01-Oct-2014
WO-2015038811-A2 Liquid protein formulations containing ionic liquids Inactive 11-Sep-2013
WO-2015038811-A3 Liquid protein formulations containing ionic liquids Inactive 11-Sep-2013
WO-2015038782-A1 Liquid protein formulations containing organophosphates Inactive 11-Sep-2013
WO-2015038818-A2 Liquid protein formulations containing viscosity-lowering agents Inactive 11-Sep-2013 A61K47/06
To view Arsia Therapeutics’s complete patent history, request access »

Arsia Therapeutics Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Johnson & Johnson Innovation - JLABS Accelerator/Incubator
LabCentral Accelerator/Incubator
Polaris Partners Venture Capital Minority
To view Arsia Therapeutics’s complete investors history, request access »

Arsia Therapeutics FAQs

  • When was Arsia Therapeutics founded?

    Arsia Therapeutics was founded in 2013.

  • Where is Arsia Therapeutics headquartered?

    Arsia Therapeutics is headquartered in Cambridge, MA.

  • What industry is Arsia Therapeutics in?

    Arsia Therapeutics’s primary industry is Drug Delivery.

  • Is Arsia Therapeutics a private or public company?

    Arsia Therapeutics is a Private company.

  • What is the current valuation of Arsia Therapeutics?

    The current valuation of Arsia Therapeutics is .

  • What is Arsia Therapeutics’s current revenue?

    The current revenue for Arsia Therapeutics is .

  • Who are Arsia Therapeutics’s investors?

    Johnson & Johnson Innovation - JLABS, LabCentral, and Polaris Partners have invested in Arsia Therapeutics.

  • Who are Arsia Therapeutics’s competitors?

    RheoSense Inc., Antibody Production Services, Domainex, Agrisera, and Protein Ark are some of the 21 competitors of Arsia Therapeutics.

  • When was Arsia Therapeutics acquired?

    Arsia Therapeutics was acquired on 16-Nov-2016.

  • Who acquired Arsia Therapeutics?

    Arsia Therapeutics was acquired by Eagle Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process